Does IFOSFAMIDE Cause Second primary malignancy? 223 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 223 reports of Second primary malignancy have been filed in association with IFOSFAMIDE (IFEX). This represents 1.3% of all adverse event reports for IFOSFAMIDE.
223
Reports of Second primary malignancy with IFOSFAMIDE
1.3%
of all IFOSFAMIDE reports
102
Deaths
39
Hospitalizations
How Dangerous Is Second primary malignancy From IFOSFAMIDE?
Of the 223 reports, 102 (45.7%) resulted in death, 39 (17.5%) required hospitalization, and 28 (12.6%) were considered life-threatening.
Is Second primary malignancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IFOSFAMIDE. However, 223 reports have been filed with the FAERS database.
What Other Side Effects Does IFOSFAMIDE Cause?
Off label use (2,281)
Febrile neutropenia (2,225)
Disease progression (1,912)
Neutropenia (1,509)
Drug ineffective (1,331)
Thrombocytopenia (1,227)
Anaemia (1,067)
Product use in unapproved indication (890)
Pyrexia (752)
Sepsis (712)
What Other Drugs Cause Second primary malignancy?
CYCLOPHOSPHAMIDE (1,247)
DOXORUBICIN (1,151)
VINCRISTINE (908)
IMATINIB (763)
PALBOCICLIB (658)
RITUXIMAB (646)
RUXOLITINIB (611)
ETOPOSIDE (573)
PREDNISONE (517)
OCTREOTIDE (496)
Which IFOSFAMIDE Alternatives Have Lower Second primary malignancy Risk?
IFOSFAMIDE vs IGURATIMOD
IFOSFAMIDE vs ILOPERIDONE
IFOSFAMIDE vs ILOPROST
IFOSFAMIDE vs IMATINIB
IFOSFAMIDE vs IMBRUVICA